Kano Therapeutics

Cambridge, United States

Kano Therapeutics develops single-stranded DNA for targeted gene correction.

$5.0M raised

Aug 2024

Seed

Biotechnology Health Care Medical

Top Investors

Vsquared VenturesEngine VenturesTaihill VentureMetaplanetAmino Collective

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kano Therapeutics

How much funding has Kano Therapeutics raised?

Kano Therapeutics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in August 2024.

Who are Kano Therapeutics's investors?

Kano Therapeutics's investors include Vsquared Ventures, Engine Ventures, Taihill Venture, Metaplanet, Amino Collective.

Where is Kano Therapeutics headquartered?

Kano Therapeutics is headquartered in Cambridge, United States.

What does Kano Therapeutics do?

Kano Therapeutics develops single-stranded DNA for targeted gene correction.

What stage is Kano Therapeutics at?

Kano Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 12, 2024.

MLA

"Kano Therapeutics — Funding & Investors." VCBacked, August 12, 2024, https://www.vcbacked.co/company/kano-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2024). Kano Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/kano-therapeutics

Wikipedia (cite web)

{{cite web |title=Kano Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kano-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 12, 2024.

Similar Companies in Biotechnology